Wnt myofibroblastic activation of hepatic stellate cells (Rattus norvegicus)
From WikiPathways
Description
This pathway is modeled after figure 5 from Kweon et al. The WNT signaling pathway activates Beta-catenin which inhibits serine and cysteine proteases. This inhibition of these proteins increases MeCP2 stability and induces epigenetic repression of Ppar-y leading to hepatic stellate cell myofibroblastic activation causing liver fibrosis which can lead to liver cirrhosis.
Quality Tags
Ontology Terms
Bibliography
- Kweon SM, Chi F, Higashiyama R, Lai K, Tsukamoto H; ''Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.''; PLoS One, 2016 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
Beta-Catenin | Protein | ENSRNOP00000068620 (Ensembl Rat) | |
DPI | Metabolite | 3101 (PubChem-compound) | |
FJ9 | Metabolite | Small molecule inhibitor, see article for more information. Identifier not found | |
Leupeptin | Metabolite | 72429 (PubChem-compound) | |
MeCP2 | Protein | ENSRNOG00000056659 (Ensembl) | |
Ppar-y | Protein | ENSRNOG00000008839 (Ensembl) | |
Ser/Cys Peptidases | Protein | General Term | |
Wnt-3a | Protein | ENSRNOT00000064505 (Ensembl) |
Annotated Interactions
No annotated interactions